Source comparison
CJC + Ipamorelin vs CJC-1295 No DAC & Ipamorelin
A researcher orders a vial labeled 'CJC + Ipamorelin' from one supplier and 'CJC-1295 no DAC & Ipamorelin' from another. Then spends an hour online trying to confirm they ordered the same thing. That confusion isn't your fault. The peptide research space has n
This comparison does not assign a generated winner or score.
- A researcher orders a vial labeled 'CJC + Ipamorelin' from one supplier and 'CJC-1295 no DAC & Ipamorelin' from another. Then spends an hour online trying to confirm they ordered the same thing. That confusion isn't your fault. The peptide research space has no standardized naming convention, so suppliers use shorthand that assumes you already know what CJC means. You don't get a product insert explaining that 'CJC' is vendor shorthand for 'CJC-1295 without Drug Affinity Complex modification.'
- Our team has worked with peptide researchers navigating this exact labeling gap for years. The compounds are identical. The names are just inconsistently shortened.
- What is CJC + Ipamorelin same as CJC-1295 no DAC & Ipamorelin?
- Yes, 'CJC + Ipamorelin' and 'CJC-1295 no DAC & Ipamorelin' refer to the same peptide combination. CJC is vendor shorthand for CJC-1295 no DAC (modified growth hormone-releasing hormone), paired with Ipamorelin (a selective ghrelin receptor agonist). The two peptides synergistically stimulate pulsatile growth hormone release. CJC-1295 no DAC extends the amplitude of each pulse, while Ipamorelin triggers the pulse itself without elevating cortisol or prolactin.
- The naming inconsistency exists because 'CJC-1295 no DAC' is technically a misnomer that stuck. The original CJC-1295 (with DAC) and the modified growth hormone-releasing hormone analog most researchers use (no DAC) are structurally different. One has a half-life of 8 days, the other approximately 30 minutes. When suppliers write 'CJC,' they mean the short-acting no-DAC version unless explicitly stated otherwise. This article covers why the naming split happened, what the peptides actually do at the receptor level, and how to verify you're getting the compound you intended when labels don't match across sources.